- Home
- RARE vs ATHM Comparison
RARE vs ATHM Comparison
Compare RARE & ATHM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RARE | ATHM |
|---|---|---|
| Founded | 2010 | 2008 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 2.5B |
| IPO Year | 2013 | 2013 |
Fundamental Metrics
Financial Performance| Metric | RARE | ATHM |
|---|---|---|
| Price | $21.26 | $19.18 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 19 | 1 |
| Target Price | ★ $66.32 | $28.00 |
| AVG Volume (30 Days) | ★ 2.0M | 546.8K |
| Earning Date | 05-04-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 9.51% |
| EPS Growth | ★ 7.31 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $673,000,000.00 | N/A |
| Revenue This Year | $13.40 | $5.67 |
| Revenue Next Year | $42.83 | $2.17 |
| P/E Ratio | ★ N/A | $12.13 |
| Revenue Growth | ★ 20.13 | N/A |
| 52 Week Low | $18.41 | $17.87 |
| 52 Week High | $40.54 | $30.85 |
Technical Indicators
Market Signals| Indicator | RARE | ATHM |
|---|---|---|
| Relative Strength Index (RSI) | 37.40 | 36.73 |
| Support Level | $19.61 | N/A |
| Resistance Level | $25.46 | $23.96 |
| Average True Range (ATR) | 0.98 | 0.71 |
| MACD | 0.03 | -0.13 |
| Stochastic Oscillator | 39.06 | 37.97 |
Price Performance
Historical ComparisonAbout RARE Ultragenyx Pharmaceutical Inc.
Ultragenyx Pharmaceutical Inc is a USA-based biopharmaceutical company. It identifies, acquires, develops, and commercializes novel products for the treatment of serious rare and ultra-rare diseases, with a focus on serious, debilitating genetic diseases. The company's medicine portfolio includes Crysvita, Dojolvi and Mepsevii. Crysvita is indicated for the treatment of X-linked hypophosphatemia (XLH) in adult and pediatric patients 1 year of age and older. Mepsevii is indicated in pediatric and adult patients for the treatment of Mucopolysaccharidosis VII.
About ATHM Autohome Inc.
Founded in 2008 as a media content platform, Autohome is the leading online automobile platform in China, ranking first among automotive service platforms in terms of mobile daily active users, according to QuestMobile. Through its two websites, autohome.com.cn and che168.com, Autohome delivers comprehensive, independent and interactive content and tools to automobile consumers as well as a full suite of services to automakers and dealers. According to iResearch, the company was the largest online automotive advertising and lead generation service provider with 30% market share, in terms of media services and lead generation revenue, in China's online auto platform media advertising market.